C12Y 113/00
Oxidoreductases acting on single donors with incorporation of molecular oxygen
Official title: Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
C12Y113/00 (Oxidoreductases acting on single donors with incorporation of molecular oxygen) appears on 650 US grants and 954 published applications in this corpus.
Search patents in C12Y- Granted patents
- 650
- Published applications
- 954
- Assignees
- 364
- Inventors
- 1,599
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 6 | 0 |
| 1995 | 5 | 0 |
| 1996 | 14 | 0 |
| 1997 | 17 | 0 |
| 1998 | 10 | 0 |
| 1999 | 6 | 0 |
| 2000 | 11 | 0 |
| 2001 | 11 | 3 |
| 2002 | 10 | 2 |
| 2003 | 5 | 14 |
| 2004 | 5 | 8 |
| 2005 | 5 | 8 |
| 2006 | 6 | 4 |
| 2007 | 5 | 20 |
| 2008 | 1 | 23 |
| 2009 | 10 | 17 |
| 2010 | 15 | 19 |
| 2011 | 9 | 24 |
| 2012 | 16 | 24 |
| 2013 | 6 | 19 |
| 2014 | 17 | 60 |
| 2015 | 27 | 56 |
| 2016 | 48 | 59 |
| 2017 | 41 | 72 |
| 2018 | 40 | 58 |
| 2019 | 53 | 84 |
| 2020 | 51 | 64 |
| 2021 | 35 | 54 |
| 2022 | 35 | 60 |
| 2023 | 42 | 47 |
| 2024 | 22 | 60 |
| 2025 | 28 | 47 |
| 2026 | 23 | 48 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cleaning composition comprising an engineered fatty acid alpha-dioxygenase15 Sep 2026US 12,735,658 B2The Procter & Gamble Company
- Herbicide tolerance genes and methods of use thereof1 Sep 2026US 12,723,255 B2Monsanto Technology LLC
- Pathogen detection method and apparatus7 Jul 2026US 12,674,798 B2Industry-Academic Cooperation Foundation, Yeungnam University
- Lipids and lipid nanoparticle formulations for delivery of nucleic acids30 Jun 2026US 12,667,627 B2Acuitas Therapeutics, Inc.
- Multipartite luciferase16 Jun 2026US 12,655,398 B2Promega Corporation
- Genetically engineered cd4 t-cells for in situ synthesis of proteins8 Oct 2026US 2026/0308515 A1SRI International
- Photoswitch protein8 Oct 2026US 2026/0308556 A1Kanagawa Institute of Industrial Science and Technology
- Modified rna with decreased immunostimulatory properties24 Sep 2026US 2026/0284227 A1CureVac AG
- Fully genetically encoded nad+protein probe based on resonance energy transfer,and preparation method therefor and use thereof17 Sep 2026US 2026/0275323 A1Shenzhen Institutes of Advanced Technology
- Methods for producing modified betalains in yeast3 Sep 2026US 2026/0258343 A1Danmarks Tekniske Universitet
Most cited
By later US patents
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996
- Induction of a protective immune response in a mammal by injecting a DNA sequence885US 5,589,466 AVical Incorporated · 1996
- N-2 substituted purines806US 5,459,255 AIsis Pharmaceuticals, Inc. · 1995
- Herbicide resistance genes653US 8,916,752 B2Dow AgroSciences LLC · 2014
- Herbicide resistance genes649US 8,283,522 B2Dow AgroSciences LLC · 2012